Literature DB >> 11769879

Obesity, interrelated mechanisms, and exposures and kidney cancer.

M A Moyad1.   

Abstract

Obesity has been shown to increase the risk or be associated with numerous conditions from cardiovascular disease and type II diabetes to erectile dysfunction and osteoarthritis. Obesity may also be associated with numerous cancers, and kidney cancer or renal-cell cancer (RCC) may have one of the strongest correlations to obesity compared with cancer at any other site. Almost every epidemiologic investigation has demonstrated an association that tends to affect women more than men, but both genders are impacted. In general, past studies suggest that with increasing weight, a threshold point exists whereby a certain range of body mass index dramatically changes risk. Men and women at the most extreme ends of obesity tend to have the highest risk or only risk in past studies. Individuals at the more extreme ends of obesity may be affected by an almost indefinite number of mechanisms and exposures that could determine incidence and possibly prognosis. For example, higher estrogen levels, elevated insulin levels, a greater concentration of growth factors in adipose tissue, hypertension, cholesterol metabolism abnormalities, and immune malfunction are just some of the potential mechanisms that may increase kidney cancer risk. Obese individuals may also have lower serum levels of vitamin D and engage in less physical activity. Smoking or genetic predisposition to RCC may synergistically contribute to the effect of obesity on risk. The potential mechanisms and associations are numerous and complex. Regardless of the actual cancer risk now and in the future, the overall effect of obesity on general health is clear, and this should be kept in mind in the discussion between health professional and patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11769879

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  12 in total

1.  [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].

Authors:  S Waalkes; H Eggers; J Rustemeier; G Wegener; F Jentzmik; M Schrader; R Hofmann; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?

Authors:  Sandra Steffens; Viktor Grünwald; Kristina I Ringe; Christoph Seidel; Hendrik Eggers; Mark Schrader; Frank Wacker; Markus A Kuczyk; Andres J Schrader
Journal:  Oncologist       Date:  2011-10-21

Review 3.  Putative environmental-endocrine disruptors and obesity: a review.

Authors:  Mai A Elobeid; David B Allison
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

4.  Effect of 7,12-Dimethylbenz(α)anthracene on the Expression of miR-330, miR-29a, miR-9-1, miR-9-3 and the mTORC1 Gene in CBA/Ca Mice.

Authors:  Andras Tomesz; Laszlo Szabo; Richard Molnar; Arpad Deutsch; Richard Darago; Domokos Mathe; Ferenc Budan; Nowrasteh Ghodratollah; Timea Varjas; Balazs Nemeth; Istvan Kiss
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.

Authors:  William T Lowrance; R Houston Thompson; David S Yee; Matthew Kaag; S Machele Donat; Paul Russo
Journal:  BJU Int       Date:  2009-07-06       Impact factor: 5.588

6.  Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.

Authors:  Andres Jan Schrader; Julia Rustemeier; Jan Christoph Rustemeier; Nina Timmesfeld; Zoltan Varga; Axel Hegele; Peter Jochen Olbert; Rainer Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-20       Impact factor: 4.553

7.  Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.

Authors:  Jeanette E Eckel-Passow; Daniel J Serie; Brian M Bot; Richard W Joseph; Steven N Hart; John C Cheville; Alexander S Parker
Journal:  Carcinogenesis       Date:  2013-12-28       Impact factor: 4.944

8.  Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data.

Authors:  Mai A Elobeid; Miguel A Padilla; David W Brock; Douglas M Ruden; David B Allison
Journal:  Int J Environ Res Public Health       Date:  2010-07-23       Impact factor: 3.390

9.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

10.  Immunotherapy of genitourinary malignancies.

Authors:  Teruo Inamoto; Haruhito Azuma
Journal:  J Oncol       Date:  2012-03-05       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.